Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × Erlotinib Hydrochloride × 1 year × Clear all

Squamous Cell Carcinoma of Head and Neck, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00076310 2025-06-26

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Phase 2 Active not recruiting

50 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Clinical Trials

POTENTIATE

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer